Skip to content
healthcare.dev
Get a free key

Gadoterate Meglumine

NDC 65219-082, gadoterate meglumine, injection, from Fresenius Kabi USA, LLC.

Product NDC
65219-082
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215304
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-082 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GADOTERATE MEGLUMINE376.9 mg/mL

Pharmacologic classes

Gadolinium-based Contrast Agent [EPC]; Magnetic Resonance Contrast Activity [MoA]

Package NDCNDC-11Package
65219-082-106521900821010 CARTON in 1 BOX (65219-082-10) / 1 VIAL in 1 CARTON (65219-082-01) / 10 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e0655aac-9508-4141-94f5-fcca6af1c41d

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65219-082

Use it

Look up 65219-082 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-082 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-082. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.